Loading…
Company shows increased loss per share and higher sales compared to Q3 last year.
Aspire Biopharma Holdings, Inc. announced Aspire Biopharma Holdings, Inc. reported Q3 earnings with an EPS of $(0.04) compared to $(0.01) in the same period last year, and sales of $1,941,000.
The announcement cited EPS: $(0.04), and EPS YoY: $(0.01).
Aspire Biopharma Holdings, Inc. has a free float of 91,673,000 shares and 138,446,000 shares outstanding.
This summary was generated by AI from public sources and may contain errors. Not financial advice. Trade at your own risk.